DOI 10.1016/j.ijbiomac.2025.149727
Targeting the gut-vascular axis: Chondroitin sulfate C enhances microbial hydrogen sulfide production to alleviate hypertension.
Аннотация
Hypertension remains a major global health challenge, often associated with vascular remodeling, oxidative stress, inflammation, and gut microbiota dysbiosis. In this study, we explored the effects of chondroitin sulfate C, a special bioactive substance, on blood pressure regulation and its potential mechanism involving the gut-vascular axis. Hypertensive rats induced by L-NAME were treated with chondroitin sulfate C, which resulted in significant reductions in both systolic and diastolic blood pressure, as well as improvements in aortic histology. Mechanistically, chondroitin sulfate C mitigated oxidative stress, as evidenced by increased antioxidant enzyme activity and decreased ROS production. Inflammatory markers, including TNF-α and adhesion molecules, were significantly reduced. Notably, chondroitin sulfate C promoted the growth of Desulfovibrio in the gut, leading to increased H2S production, which activated the AKT/eNOS pathway, restored NO levels, and enhanced vasodilation. These findings suggest that gut-derived H2S plays a critical role in blood pressure regulation and highlight the therapeutic potential of chondroitin sulfate C in hypertension management.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.